Olanzapine-induced obsessive-compulsive symptoms in a patient with bipolar II disorder

Psychopharmacology

Volumn 162, Issue 1, 2002, Pages 87-88

  Jonkers, Frits ^a   De Haan, Lieuwe ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; CARBAMAZEPINE; LITHIUM CARBONATE; OLANZAPINE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; DRUG DERIVATIVE; PIRENZEPINE;

ADULT; ANXIETY; ARTICLE; BEHAVIOR THERAPY; CASE REPORT; CLINICAL FEATURE; CONTROLLED STUDY; DELUSION; DISEASE COURSE; DOSE RESPONSE; DRUG WITHDRAWAL; FEAR; FEMALE; FOLLOW UP; HUMAN; MANIC DEPRESSIVE PSYCHOSIS; OBSESSION; PRIORITY JOURNAL; BIPOLAR DISORDER; CHEMICALLY INDUCED DISORDER; OBSESSIVE COMPULSIVE DISORDER; PSYCHOLOGICAL ASPECT;

ADULT; BIPOLAR DISORDER; CASE REPORT; FEMALE; HUMAN; OBSESSIVE-COMPULSIVE DISORDER; PIRENZEPINE; BENZODIAZEPINES; HUMANS;

EID: 0035987404     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-002-1062-x     Document Type: Article

References (9)

1. Clozapine and obsessions in patients with recent-onset schizophrenic disorders
2. Obsessive-compulsive symptoms and clozapine
3. Exacerbation of obsessive-compulsive symptoms associated with clozapine
4. 2A promotor polymorphism -1 438G/A, anorexia nervosa, and obsessive-compulsive disorder
5. Olanzapine in treatment-resistant bipolar disorder
6. Worsening of obsessive-compulsive symptoms following treatment with olanzapine
7. Olanzapine induced obsessive-compulsive disorder
8. Obsessive-compulsive disorder in schizophrenia: Epidemiologic and biologic overlap
9. Olanzapine vs placebo in the treatment of acute mania